Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial - de Gramont, A; Van Cutsem, E; Schmoll, H J (Lancet Oncol, 2012)